Tevogen Bio Holdings (TVGN) Profit After Tax (2022 - 2026)
Tevogen Bio Holdings (TVGN) reported Profit After Tax of -$5.4 million for Q1 2026, up 47.47% on a YoY basis from -$3.7 million in Q1 2025, and down 16.43% quarter-over-quarter from -$4.7 million in Q4 2025.
Tevogen Bio Holdings (TVGN) Profit After Tax (2022 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Profit After Tax for 5 years, with the latest figure at -$5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 47.47% year-over-year to -$5.4 million; the trailing twelve-month figure through Mar 2026 stood at -$21.4 million (up 39.61% YoY), and the FY2025 full-year result was -$26.3 million, down 91.41% from the prior year.
- Profit After Tax for Q1 2026 stood at -$5.4 million, down from -$4.7 million in the prior quarter.
- The five-year high for Profit After Tax was $11.3 million in Q1 2024, with the low at -$30.8 million in Q1 2023.
- Historically, Profit After Tax has averaged -$6.0 million across 5 years, with a median of -$5.4 million in 2026.
- Annual changes were most pronounced in 2023 — Profit After Tax tumbled 118247.48% — and 2024, when it surged 136.63%.
- Tevogen Bio Holdings' Profit After Tax stood at $2.6 million in 2022, then tumbled by 238.93% to -$3.6 million in 2023, then slumped by 160.02% to -$9.4 million in 2024, then soared by 50.47% to -$4.7 million in 2025, then slipped by 16.43% to -$5.4 million in 2026.
- The last three Profit After Tax figures came in at -$5.4 million (Q1 2026), -$4.7 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -56.74 Mn |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | -5.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.45 Mn |
| Dec 31, 2025 | -4.68 Mn |
| Sep 30, 2025 | -5.73 Mn |
| Jun 30, 2025 | -5.50 Mn |
| Mar 31, 2025 | -10.37 Mn |
| Dec 31, 2024 | -9.44 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Jun 30, 2024 | -9.66 Mn |
| Mar 31, 2024 | 11.26 Mn |
| Dec 31, 2023 | -3.63 Mn |
| Sep 30, 2023 | -3.90 Mn |
| Jun 30, 2023 | -22.18 Mn |
| Mar 31, 2023 | -30.76 Mn |
| Dec 31, 2022 | 2.61 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 206,998.00 |
| Mar 31, 2022 | -25,988.00 |